[1] Klionsky DJ, Abdelmohsen K, Abe A, et al.  Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)[J]. Autophagy, 2016, 12(1): 1-222.   doi: 10.1080/15548627.2015.1100356
[2] Nagelkerke A, Bussink J, Geurts-Moespot A, et al.  Therapeutic targeting of autophagy in cancer. Part II: pharmacological modulation of treatment-induced autophagy[J]. Semin Cancer Biol, 2015, 31: 99-105.   doi: 10.1016/j.semcancer.2014.06.001
[3] Ozpolat B, Benbrook DM.  Targeting autophagy in cancer management-strategies and developments[J]. Cancer Manag Res, 2015, 7: 291-299.   doi: 10.2147/CMAR.S34859
[4] Panda PK, Mukhopadhyay S, Das DN, et al.  Mechanism of autophagic regulation in carcinogenesis and cancer therapeutics[J]. Semin Cell Dev Biol, 2015, 39: 43-55.   doi: 10.1016/j.semcdb.2015.02.013
[5] Liang XH, Jackson S, Seaman M, et al.  Induction of autophagy and inhibition of tumorigenesis by beclin 1[J]. Nature, 1999, 402(6762): 672-676.   doi: 10.1038/45257
[6] Aita VM, Liang XH, Murty VV, et al.  Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21[J]. Genomics, 1999, 59(1): 59-65.   doi: 10.1006/geno.1999.5851
[7] Young AR, Narita M, Ferreira M, et al.  Autophagy mediates the mitotic senescence transition[J]. Genes Dev, 2009, 23(7): 798-803.   doi: 10.1101/gad.519709
[8] Nam HY, Han MW, Chang HW, et al.  Radioresistant cancer cells can be conditioned to enter senescence by mTOR inhibition[J]. Cancer Res, 2013, 73(14): 4267-4277.   doi: 10.1158/0008-5472.CAN-12-3516
[9] Mizushima N, Ohsumi Y, Yoshimori T.  Autophagosome formation in mammalian cells[J]. Cell Struct Funct, 2002, 27(6): 421-429.   doi: 10.1247/csf.27.421
[10] Lao Y, Xu N.  Autophagy in Cancer Chemoprevention: Identification of Novel Autophagy Modulators with Anticancer Potential[J]. Methods Mol Biol, 2016, 1379: 151-163.   doi: 10.1007/978-1-4939-3191-0_14
[11] Mathew R, Karantza-Wadsworth V, White E.  Role of autophagy in cancer[J]. Nat Rev Cancer, 2007, 7(12): 961-967.   doi: 10.1038/nrc2254
[12] Schleicher SM, Moretti L, Varki V, et al.  Progress in the unraveling of the endoplasmic reticulum stress/autophagy pathway and cancer: implications for future therapeutic approaches[J]. Drug Resist Updat, 2010, 13(3): 79-86.   doi: 10.1016/j.drup.2010.04.002
[13] Kim BM, Hong Y, Lee S, et al.  Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy[J]. Int J Mol Sci, 2015, 16(11): 26880-26913.   doi: 10.3390/ijms161125991
[14] Daido S, Yamamoto A, Fujiwara K, et al.  Inhibition of the DNA-dependent protein kinase catalytic subunit radiosensitizes malignant glioma cells by inducing autophagy[J]. Cancer Res, 2005, 65(10): 4368-4375.   doi: 10.1158/0008-5472.CAN-04-4202
[15] Paglin S, Lee NY, Nakar C, et al.  Rapamycin-sensitive pathway regulates mitochondrial membrane potential, autophagy, and survival in irradiated MCF-7 cells[J]. Cancer Res, 2005, 65(23): 11061-11070.   doi: 10.1158/0008-5472.CAN-05-1083
[16] Kim KW, Moretti L, Mitchell LR, et al.  Endoplasmic reticulum stress mediates radiation-induced autophagy by perk-eIF2alpha in caspase-3/7-deficient cells[J]. Oncogene, 2010, 29(22): 3241-3251.   doi: 10.1038/onc.2010.74
[17] Zhang B, Wang M, Yang Y, et al.  ERp29 is a radiation-responsive gene in IEC-6 cell[J]. J Radiat Res, 2008, 49(6): 587-596.   doi: 10.1269/jrr.08014
[18] Nardella C, Chen Z, Salmena L, et al.  Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events[J]. Genes Dev, 2008, 22(16): 2172-2177.   doi: 10.1101/gad.1699608
[19] Palumbo S, Pirtoli L, Tini P, et al.  Different involvement of autophagy in human malignant glioma cell lines undergoing irradiation and temozolomide combined treatments[J]. J Cell Biochem, 2012, 113(7): 2308-2318.   doi: 10.1002/jcb.24102
[20] Wang JH, Chen WL, Li JM, et al.  Prognostic significance of 2-hydroxyglutarate levels in acute myeloid leukemia in China[J]. Proc Natl Acad Sci USA, 2013, 110(42): 17017-17022.   doi: 10.1073/pnas.1315558110
[21] Rouschop KM, van den Beucken T, Dubois L, et al.  The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5[J]. J Clin Invest, 2010, 120(1): 127-141.   doi: 10.1172/JCI40027
[22] Ferlay J, Soerjomataram I, Dikshit R, et al.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5): E359-E386.   doi: 10.1002/ijc.29210
[23] van Dijk BA, Brands MT, Geurts SM, et al.  Trends in oral cavity cancer incidence, mortality, survival and treatment in the Netherlands[J]. Int J Cancer, 2016, 139(3): 574-583.   doi: 10.1002/ijc.30107
[24] Wu SY, Liu YW, Wang YK, et al.  Ionizing radiation induces autophagy in human oral squamous cell carcinoma[J]. J BUON, 2014, 19(1): 137-44.
[25] Kim KW, Hwang M, Moretti L, et al.  Autophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer[J]. Autophagy, 2008, 4(5): 659-668.   doi: 10.4161/auto.6058
[26] Kim KW, Moretti L, Mitchell LR, et al.  Combined Bcl-2/mammalian target of rapamycin inhibition leads to enhanced radiosensitization via induction of apoptosis and autophagy in non-small cell lung tumor xenograft model[J]. Clin Cancer Res, 2009, 15(19): 6096-6105.   doi: 10.1158/1078-0432.CCR-09-0589
[27] Kim KW, Myers CJ, Jung DK, et al.  NVP-BEZ-235 enhances radiosensitization via blockade of the PI3K/mTOR pathway in cisplatin-resistant non-small cell lung carcinoma[J]. Genes Cancer, 2014, 5(7/8): 293-302.   doi: 10.18632/genesandcancer.27
[28] Apel A, Herr I, Schwarz H, et al.  Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy[J]. Cancer Res, 2008, 68(5): 1485-1494.   doi: 10.1158/0008-5472
[29] Albert JM, Kim KW, Cao C, et al.  Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer[J]. Mol Cancer Ther, 2006, 5(5): 1183-1189.   doi: 10.1158/1535-7163.MCT-05-0400
[30] Pang XL, He G, Liu YB, et al.  Endoplasmic reticulum stress sensitizes human esophageal cancer cell to radiation[J]. World J Gastroenterol, 2013, 19(11): 1736-1748.   doi: 10.3748/wjg.v19.i11.1736
[31] Ondrej M, Cechakova L, Durisova K, et al.  To live or let die: Unclear task of autophagy in the radiosensitization battle[J]. Radiother Oncol, 2016, 119(2): 265-275.   doi: 10.1016/j.radonc.2016.02.028
[32] Miller KD, Siegel RL, Lin CC, et al.  Cancer treatment and survivorship statistics, 2016[J]. CA Cancer J Clin, 2016, 66(4): 271-289.   doi: 10.3322/caac.21349
[33] Siegel RL, Miller KD, Jemal A.  Cancer Statistics, 2017[J]. CA Cancer J Clin, 2017, 67(1): 7-30.   doi: 10.3322/caac.21387
[34] Chiu HW, Lin SW, Lin LC, et al.  Synergistic antitumor effects of radiation and proteasome inhibitor treatment in pancreatic cancer through the induction of autophagy and the downregulation of TRAF6[J]. Cancer Lett, 2015, 365(2): 229-239.   doi: 10.1016/j.canlet.2015.05.025
[35] Yuk JM, Shin DM, Song KS, et al.  Bacillus calmette-guerin cell wall cytoskeleton enhances colon cancer radiosensitivity through autophagy[J]. Autophagy, 2010, 6(1): 46-60.   doi: 10.4161/auto.6.1.10325
[36] Schiavina R, Bianchi L, Borghesi M, et al.  Predicting survival in node-positive prostate cancer after open, laparoscopic or robotic radical prostatectomy: A competing risk analysis of a multi-institutional database[J]. Int J Urol, 2016, 23(12): 1000-1008.   doi: 10.1111/iju.13203
[37] Koukourakis MI, Kalamida D, Mitrakas A, et al.  Intensified autophagy compromises the efficacy of radiotherapy against prostate cancer[J]. Biochem Biophys Res Commun, 2015, 461(2): 268-274.   doi: 10.1016/j.bbrc.2015.04.014
[38] Cao C, Subhawong T, Albert JM, et al.  Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells[J]. Cancer Res, 2006, 66(20): 10040-10047.   doi: 10.1158/0008-5472.CAN-06-0802
[39] Azad MB, Gibson SB.  Role of BNIP3 in proliferation and hypoxia-induced autophagy: implications for personalized cancer therapies[J]. Ann N Y Acad Sci, 2010, 1210: 8-16.   doi: 10.1111/j.1749-6632.2010.05778.x